Table 1. Comparison of baseline demographic and clinical characteristics in two groups.
| Group | 3TC/DTG (N=190) | B/F/TAF (N=190) | P |
|---|---|---|---|
| Age (year, mean±sd) | 39.3±14.4 | 37.7±12.7 | 0.259 |
| Gender (male, %) | 173 (91.1) | 180 (94.7) | 0.162 |
| HIV-1 RNA (log10 copies per millilitre, mean±sd) | 4.46±0.75 | 4.75±0.69 | <0.001 |
| HVL, >500 000 copies per millilitre, n (%) | 8 (4.4) | 22 (11.6) | 0.001 |
| CD4+count (cells per microlitre, mean±sd) | 301.3±185.8 | 289.2±188.8 | 0.538 |
| >200, n (%) | 124 (69.6) | 130 (68.4) | 0.797 |
| CD4/CD8 ratio (mean±sd) | 0.33±0.23 | 0.29±0.20 | 0.102 |
| ALT (U l−1, mean±sd) | 29.9±24.6 | 34.2±38.6 | 0.302 |
| AST (U l−1, mean±sd) | 25.6±16.1 | 28.3±27.9 | 0.359 |
| ALP (U l−1, mean±sd) | 76.5±27.2 | 74.8±22.5 | 0.543 |
| TBIL (mmol l−1, mean±sd) | 13.2±7.7 | 13.8±7.0 | 0.321 |
| sCr (µmol l−1, mean±sd) | 78.8±36.6 | 63.9±12.9 | 0.144 |
| eGFR (ml∙min−1∙1.73 m−2) | 108.8±27.1 | 118.8±23.6 | <0.001 |
| Cys-c (mg l−1, mean±sd) | 0.84±0.46 | 075±0.20 | 0.197 |
| RBP (mg l−1, mean±sd) | 46.0±13.2 | 43.8±10.8 | 0.557 |
| TC (mmol l−1, mean±sd) | 4.4±1.0 | 4.3±0.8 | 0.581 |
| TG (mmol l−1, mean±sd) | 1.7±1.1 | 1.7±1.0 | 0.691 |
| HDL-C (mmol l−1, mean±sd) | 1.1±0.3 | 1.0±0.3 | 0.040 |
| LDL-C (mmol l−1, mean±sd) | 2.9±0.9 | 2.8±0.7 | 0.805 |
| AIP | 0.16±0.32 | 0.20±0.28 | 0.176 |
HVL, high viral load; RBP, retinol-binding protein; TBIL, total bilirubin.